These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16818778)

  • 1. GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.
    Zoeteweij JP; Epperson DE; Porter JD; Zhang CX; Frolova OY; Constantinides AP; Fuhrmann SR; El-Amine M; Tian JH; Ellingsworth LR; Glenn GM
    J Immunol; 2006 Jul; 177(2):1197-207. PubMed ID: 16818778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
    Mathias-Santos C; Rodrigues JF; Sbrogio-Almeida ME; Connell TD; Ferreira LC
    Clin Vaccine Immunol; 2011 Aug; 18(8):1243-51. PubMed ID: 21677110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
    Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
    PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant.
    Amorim JH; Diniz MO; Cariri FA; Rodrigues JF; Bizerra RS; Gonçalves AJ; de Barcelos Alves AM; de Souza Ferreira LC
    Vaccine; 2012 Jan; 30(5):837-45. PubMed ID: 22178517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
    Beignon AS; Briand JP; Muller S; Partidos CD
    Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of mucosal and systemic immune responses following sublingual immunization.
    Negri DR; Riccomi A; Pinto D; Vendetti S; Rossi A; Cicconi R; Ruggiero P; Del Giudice G; De Magistris MT
    Vaccine; 2010 Jun; 28(25):4175-80. PubMed ID: 20412876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
    Norton EB; Lawson LB; Freytag LC; Clements JD
    Clin Vaccine Immunol; 2011 Apr; 18(4):546-51. PubMed ID: 21288994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
    de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells.
    Guebre-Xabier M; Hammond SA; Epperson DE; Yu J; Ellingsworth L; Glenn GM
    J Virol; 2003 May; 77(9):5218-25. PubMed ID: 12692224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
    Greene CJ; Hu JC; Vance DJ; Rong Y; Mandell L; King-Lyons N; Masso-Welch P; Mantis NJ; Connell TD
    J Leukoc Biol; 2016 Aug; 100(2):361-9. PubMed ID: 27059843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
    Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
    J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
    Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
    PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
    Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
    J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin.
    Guidry JJ; Cárdenas L; Cheng E; Clements JD
    Infect Immun; 1997 Dec; 65(12):4943-50. PubMed ID: 9393780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
    Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.